Literature DB >> 22454483

Segmentectomy for giant pulmonary sclerosing haemangiomas with high serum KL-6 levels.

Hiroaki Kuroda1, Mingyon Mun, Sakae Okumura, Ken Nakagawa.   

Abstract

We describe a 61-year old female patient with a giant pulmonary sclerosing haemangioma (PSH) and an extremely high preoperative serum KL-6 level. During an annual health screening, the patient showed a posterior mediastinal mass on chest radiography. Chest computed tomography and magnetic resonance imaging revealed a well-circumscribed 60 mm diameter nodule with a marked contrast enhancement in the left lower lobe. The preoperative serum KL-6 level was elevated to 8204 U/ml. We performed a four-port thoracoscopic basal segmentectomy and lymph node sampling for diagnosis and therapy. The postoperative diagnosis showed PSH. The serum KL-6 level decreased dramatically with tumour resection. To the best of our knowledge, this is the first report of a patient with PSH showing a high serum KL-6 level.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454483      PMCID: PMC3380972          DOI: 10.1093/icvts/ivs074

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  8 in total

1.  Sclerosing hemangioma (histiocytoma, xanthoma) of the lung.

Authors:  A A LIEBOW; D S HUBBELL
Journal:  Cancer       Date:  1956 Jan-Feb       Impact factor: 6.860

2.  A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium.

Authors:  M Devouassoux-Shisheboran; T Hayashi; R I Linnoila; M N Koss; W D Travis
Journal:  Am J Surg Pathol       Date:  2000-07       Impact factor: 6.394

3.  Sclerosing hemangioma with metastases to multiple nodal stations.

Authors:  Motoki Yano; Yosuke Yamakawa; Masanobu Kiriyama; Masaki Hara; Takayuki Murase
Journal:  Ann Thorac Surg       Date:  2002-03       Impact factor: 4.330

4.  Sclerosing hemangioma with lymph node metastasis.

Authors:  Kyung-Hee Kim; Hae-Joung Sul; Dae-Young Kang
Journal:  Yonsei Med J       Date:  2003-02       Impact factor: 2.759

5.  Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression.

Authors:  Naoko Miura; Tokujiro Yano; Fumihiro Shoji; Daigo Kawano; Tomoyoshi Takenaka; Kensaku Ito; Yosuke Morodomi; Ichiro Yoshino; Yoshihiko Maehara
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

6.  Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.

Authors:  N Kohno; M Akiyama; S Kyoizumi; M Hakoda; K Kobuke; M Yamakido
Journal:  Jpn J Clin Oncol       Date:  1988-09       Impact factor: 3.019

7.  [Diagnosis and therapeutics of 24 cases of pulmonary sclerosing hemangioma].

Authors:  Dong-Rong Situ; Hao Long; Guo-Wei Ma; Zhi-Chao Lin; Jing-Ping Yun; Tie-Hua Rong
Journal:  Ai Zheng       Date:  2008-08

8.  Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases.

Authors:  Aya Miyagawa-Hayashino; Henry D Tazelaar; Desiree J Langel; Thomas V Colby
Journal:  Arch Pathol Lab Med       Date:  2003-03       Impact factor: 5.534

  8 in total
  2 in total

Review 1.  MUC1 (CD227): a multi-tasked molecule.

Authors:  Vasso Apostolopoulos; Lily Stojanovska; Sharron E Gargosky
Journal:  Cell Mol Life Sci       Date:  2015-08-21       Impact factor: 9.261

2.  A Challenge: Pulmonary Sclerosing Haemangioma.

Authors:  Tong-Tong Li; Xu Yan; Tong Zhou; Zhen-Xiang Yu
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.